View this email in your browser ([link removed])
AVAC Advocates' Network Logo November 7, 2025
Global Health Watch is a weekly newsletter breaking down critical developments in US policies and their impact on global health. Tailored for our partners in the US and around the world, this resource offers a concise analysis of the week’s events, supporting advocates to respond to threats, challenges and opportunities in this critical period of change in global health.
This week, Zambia joined South Africa in approving injectable lenacapavir for PrEP (LEN), marking a new era of accelerated efforts to scale-up access. At the same time, there’s sharpening analyses of the major shifts in US strategy for foreign aid and global health leadership, with deep implications for the future of funding, multilateralism, and equity.
** What Lies Ahead for “America First” Global Health Strategy?
------------------------------------------------------------
It’s been six weeks since the US Department of State issued its “America First” ([link removed]) global health strategy, and global health leaders in the US are now sharing insights on the real-world implications of the new strategy. A new Think Global Health ([link removed]) piece looks at questions posed by key pillars of the US strategy: a pivot from multilateralism to bilateralism, a narrow focus on funding for commodities and frontline health workers, pooled procurement and time-limited support with the aim to ‘graduate’ countries from assistance. Meanwhile, Devex ([link removed]) offers perspectives from several leaders in the field who weigh opportunities, contradictions, and raise red flags about sidelined NGOs and the
communities they serve, reduced ambition in US global health programming, and weakened multilateral partnerships.
IMPLICATIONS: The way forward requires a major recalibration by implementers, partner countries and communities. The next chapter under this new system could exacerbate ongoing service disruptions and existing challenges in HIV prevention and treatment delivery, in particular to key populations. As funding becomes more conditional and bilateral agreements take precedence, mechanisms for community-driven priority setting, program monitoring, comprehensive data collection and sharing, and universal access to prevention tools must be preserved.
READ:
* Questions for the America First Global Health Strategy ([link removed]) —Think Global Health
* ‘America First’ in global health: Oxymoron or opportunity? ([link removed]) —Devex
** New Resources on the Foreign Aid Crisis
------------------------------------------------------------
Two powerful new resources shed light on the far-reaching impacts of the United States’ foreign aid cuts. The New Yorker released Rovina’s Choice ([link removed]) , a new documentary that follows a mother in Kenya navigating the collapse of care for her daughter living with HIV. The film captures the cascading effects of the loss of USAID support, including the dismantling of HIV wards, malaria clinics, refugee camps and health centers. Atul Gawande, the last Assistant Administrator of USAID, penned an accompanying commentary, The Shutdown of U.S.A.I.D. Has Already Killed Hundreds of Thousands ([link removed]) . Devex also launched The Aid Report ([link removed]) , a central hub for tracking funding reductions, program disruptions, and structural shifts across the ecosystem of global aid.
Meanwhile, The New York Times ([link removed]) and Washington Post ([link removed]) highlighted AVAC and the Global Health Council’s court cases against the foreign aid freeze as part of a broader test of executive power, with direct implications for foreign assistance policy. See AVAC’s trackers ([link removed]) to stay abreast of the impact of US cuts to foreign aid and HIV prevention research.
IMPLICATIONS: These resources demonstrate the scale and impact of US disengagement from global health leadership. They document how political decisions in Washington are directly destabilizing care systems, reversing progress, and threatening lives—especially in communities already facing high burdens of disease. The loss of predictable US funding has ended vital health programs around the world and is shifting the architecture for global health to a transactional model that may deprioritize equity, local voices, and long-term sustainability.
READ:
* The Shutdown of U.S.A.I.D. Has Already Killed Hundreds of Thousands ([link removed]) —The New Yorker
* The Monthslong Legal Battle to Save Foreign Aid ([link removed]) —The New York Times
* Supreme Court has expanded presidential powers under Trump. How far will it go? ([link removed]) —Washington Post
* WHO issues guidance to address drastic global health financing cuts ([link removed]) —World Health Organization
* Withdrawal of US aid has hurt South Africa’s HIV programme ([link removed]) —Spotlight South Africa
* Impact Trackers ([link removed]) —AVAC
** Zambia Approves LEN for PrEP
------------------------------------------------------------
Zambia is the latest country to approve injectable lenacapavir for PrEP (LEN), following the South African Health Products Regulatory Authority (SAHPRA) approval two weeks ago. These are the first low- and middle-income countries to approve an HIV prevention method within just months of regulatory approvals in the US and EU. Regulatory reviews are also underway in a number of additional countries, with decisions expected over the next few months.
IMPLICATIONS: These swift approvals mark a major milestone in the global HIV response and set a new precedent for accelerating the process of scaling-up biomedical interventions in high-burden regions. But approvals alone are not enough. Turning access into impact will require aligned funding, community engagement, strong demand creation, and clear strategies for equitable rollout. These early regulatory wins are a strong start, but continued advocacy is essential.
READ:
* Moving a Product to the Real World ([link removed]) —AVAC (infographic)
* Lenacapavir Regulatory Approval ([link removed]) —AVAC (infographic)
* Access Strategy for Long-Acting PrEP ([link removed]) —Gilead Sciences
* Gears of Lenacapavir for PrEP Rollout ([link removed]) —AVAC
** Webinar: Influencing the New USG Global Health MoUs and PEPFAR Strategy
------------------------------------------------------------
Monday, Nov. 10 @ 15.30 EAT
Join COMPASS with EANNASO and Data ETC for a webinar sharing tools and strategies to influence the new USG global health MoUs and ensure HIV prevention, community-led delivery, and accountability stay central under the “America First” strategy.
Register for Monday's Webinar ([link removed])
What We're Reading
• Exclusive: The Trump administration dismantled the CDC’s peer review system. Staffers scrambled to salvage it.— ([link removed]) Inside Medicine Substack
• 'You cannot fight an invisible problem': Atul Gawande on US aid cuts ([link removed]) —Devex
• Top researchers consider leaving U.S. amid funding cuts: ‘The science world is ending’ ([link removed]) —PBS Newshour
• Public Health Was a Place for Warriors Once. It Needs to Be Again. ([link removed]) —The Nation
• On Eve of Record Shutdown, Trump Administration Threatens Pain Could Worsen ([link removed]) —The New York Times
• UN staffers depart Manhattan's urban canyons for Kenya's leafy capital ([link removed]) —Devex
• New Covid virus found in wild Brazilian bats ([link removed]) —The Telegraph
• Nancy Pelosi announces her retirement from Congress ([link removed]) —Washington Post
• Vaccine-Preventable Disease: A Global Tracker ([link removed]) —Think Global Health
Webinar
November 12, 2025 at 10:00am ET / 17:00 CET
[link removed]
** From Courtrooms to Communities: Funding Advocacy to Protect HIV Responses
------------------------------------------------------------
Register Now ([link removed])
In solidarity,
AVAC
Follow us @hivpxresearch ([link removed])
[link removed] [link removed] [link removed]
Share this issue ([link removed])
AVAC Global Advocacy for HIV Prevention
+1 212 796 6423
[email protected] (mailto:
[email protected]) www.avac.org ([link removed])
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences ([link removed]) | Unsubscribe ([link removed])
